ASCRS 2023: Laser scleral microporation from Ace Vision Group
Mitchell Jackson, MD, discussed laser scleral microporation from Ace Vision Group at the 2023 ASCRS annual meeting in San Diego.
Explore More Articles
ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents AI-driven digital twin for simulation of aging eye
The Virtual Eye Simulation Analyzer is an AI-driven digital twin of the human eye designed to model aging and personalize presbyopia treatment across the lifecycle. AnnMarie Hipsley, DPT, PhD, presented a transformative concept in ophthalmic innovation: the “digital twin” of the human eye, embodied in the Virtual Eye Simulation Analyzer (VESA)—a virtual, AI-driven model capable …
read moreDynamic range of focus recovery in presbyopes after laser scleral microporation
While considered by many to be a “normal process of aging,” the loss of the dynamic focusing function of the eye, presbyopia, is a progressive disease of ocular aging. Presbyopia affects approximately 1.8 billion people globally.1 Estimated global annual productivity losses are approximately 0.037% of the global gross domesticproduct in presbyopic adults less than 65 years …
read moreData show higher patient expectations for presbyopia laser therapy among women
MARCO ISLAND, Fla. — In this Healio Video Perspective, AnnMarie Hipsley, DPT, PhD, discusses data that compared the patient-reported satisfaction levels of women and men with presbyopia after laser scleral microporation therapy. “Interestingly enough, we had more women than men, about twice as many women in the study, and women were more demanding with their satisfaction than men,” …
read more